Comparative Pharmacology
Head-to-head clinical analysis: ISOLYTE R W DEXTROSE 5 IN PLASTIC CONTAINER versus PLASMA LYTE R IN PLASTIC CONTAINER.
Peer-Reviewed Evidence
Head-to-head clinical analysis: ISOLYTE R W DEXTROSE 5 IN PLASTIC CONTAINER versus PLASMA LYTE R IN PLASTIC CONTAINER.
ISOLYTE R W/ DEXTROSE 5% IN PLASTIC CONTAINER vs PLASMA-LYTE R IN PLASTIC CONTAINER
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Isolyte R with Dextrose 5% is an intravenous solution providing electrolytes (sodium, potassium, magnesium, calcium, chloride, acetate, gluconate) and dextrose. Dextrose provides calories and may prevent ketosis; electrolytes maintain or restore acid-base balance and provide essential ions for cellular function.
Plasma-Lyte R provides electrolytes and water to maintain or restore fluid balance, with bicarbonate precursors (acetate, gluconate) to buffer metabolic acidosis.
Intravenous infusion at a rate of 125-200 mL/hour (3 mL/kg/hour) for fluid and electrolyte maintenance, adjusted based on clinical status, serum electrolytes, and glucose monitoring.
Intravenous infusion at a rate of 25-50 mL/kg body weight per 24 hours, adjusted for fluid and electrolyte needs. Typical adult maintenance dose: 1-2 L/day.
None Documented
None Documented
Not applicable as a composite solution; glucose half-life ~1.5-2 h in normal individuals, extended in renal impairment; electrolytes follow body homeostasis.
Not applicable (Plasma-Lyte R components are endogenous electrolytes and water; administered crystalloid redistributes rapidly; half-life of approximately 20-30 minutes for volume expansion due to renal excretion and redistribution into interstitial space)
Renal: ~100% as water, electrolytes, and glucose; no biliary or fecal elimination of active drug components.
Renal: >90% (electrolytes and water); Biliary/fecal: negligible (<5%)
Category C
Category C
Intravenous Electrolyte Solution
Intravenous Electrolyte Solution